The local medical landscape is excited with the emergence of retatrutide, a groundbreaking dual GIP and GLP-1 medication showing remarkable results in early trials for managing obesity. This medication https://olivebookmarks.com/story21854068/retatrutide-australia-australia-a-emerging-hope-for-weight-loss